Navigation Links
Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy

PORTLAND, Ore., Dec. 11 /PRNewswire/ -- More than 10 percent of women of Chinese and Korean heritage may be at risk for developing diabetes during pregnancy, according to a Kaiser Permanente study of 16,000 women in Hawaii that appears in the December issue of the Ethnicity and Disease journal. The study also found that Korean-American and Chinese-American women's gestational diabetes risk is one-third higher than average - and more than double that of Caucasian and African-American women.


Funded by the American Diabetes Association, the study found that Pacific Islanders, Filipinos, Puerto Ricans, and Samoans are also at higher-than-average risk - while Caucasian, Native-American, and African-American women have a lower-than-average risk.

Untreated gestational diabetes mellitus, commonly known as GDM, can lead to serious pregnancy and birthing complications, including early delivery and C-sections. It can also increase the child's risk of developing obesity later in life.

While previous studies have shown that GDM is more prevalent among Asian women and Pacific Islanders, this is the first study to separate those ethnic groups into sub-categories to find out who is at higher risk. Researchers chose Hawaii for the study because it has one of the most ethnically diverse populations in the world.

Researchers divided Asians into five ethnic sub-groups and found some striking differences: Korean and Chinese women have the greatest risk of developing GDM. Filipinos are next, but Japanese and Vietnamese women have the same risk as the rest of the population. Among three groups of Pacific Islanders, Samoans and other Pacific Islanders (including women from Fiji and Tahiti) have a higher-than-average risk, while women classified as Native Hawaiians are at average risk.* Caucasian, Native-American, and African-American women have the lowest risk for developing GDM.

"This study has important implications for diagnosis and treatment of gestational diabetes," said study lead author Kathryn Pedula, MS, a researcher at the Kaiser Permanente Center for Health Research. "All pregnant women and their caregivers need to be educated about gestational diabetes, but it is especially important for women in these ethnic groups at higher risk."

"Many previous studies have lumped all Asians and Pacific Islanders together - we now know that the risk for developing GDM varies greatly depending on your specific ethnic background," said study co-author Teresa Hillier, MD, MS, an endocrinologist and senior investigator at the Kaiser Permanente Center for Health Research. "Future studies should also look at whether women in these higher risk groups also have more complications."

This study involved 16,757 women aged 13-39, who gave birth in the Kaiser Permanente Health Plan in Hawaii between 1995 and 2003. Some women had more than one child during that time, bringing the total number of pregnancies to 22,110. Researchers obtained ethnic classification from the mothers' birth certificates on file with the Hawaii Department of Health.

All women in the Kaiser Permanente system are screened for gestational diabetes between 24-28 weeks of pregnancy. If they have GDM, they are treated as part of routine care. More than 20 percent of women in the study had elevated glucose levels, and 6.7 percent of women met the Carpenter and Coustan threshold for gestational diabetes.

"This study underscores Kaiser Permanente's commitment to identify differences in risk and clinical outcomes for different ethnic and racial groups," said Winston F. Wong, MD, MS, medical director of Kaiser Permanente's Community Benefit Disparities Improvement and Quality Initiatives. "While we cannot eliminate the increased risk of prenatal diabetes among our Korean and Chinese patients, we use this kind of research to alert and empower our health care professionals and physicians to reduce disparities and achieve the best possible outcomes for our patients and their children."

Study authors include Kathryn L. Pedula, MS, and Teresa A. Hillier, MD, MS, from the Kaiser Permanente Center for Health Research in Portland, Ore.; Mark M. Schmidt, BA, Kaiser Permanente Center for Health Research, Honolulu; Judith A. Mullen, APRN, BC, CDE, Kaiser Permanente, Honolulu, Hawaii; Marie-Aline Charles, MD, MPH, INSERM, Paris, France; and David J. Pettitt, MD, Sansum Diabetes Research Institute, Santa Barbara, Calif.

About the Kaiser Permanente Center for Health Research (

Kaiser Permanente's Center for Health Research, founded in 1964, is a nonprofit research institution dedicated to advancing knowledge to improve health. It has research sites in Portland, Ore., Honolulu and Atlanta.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services to improve the health of our members and the communities we serve. We currently serve 8.6 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to:

SOURCE Kaiser Permanente

SOURCE Kaiser Permanente
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
3. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
4. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
5. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
6. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
7. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
8. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
9. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Bay Area Women Sought for Egg Freezing Study
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):